Ennogen

Founded in 2011 by CEO John Ruprai, Ennogen is a privately owned British company offering a range of medicines, medical devices, & unlicensed medicines.

Our commercial coverage extends across the entire UK mainline and short line wholesale channels, private and NHS hospitals, community and retail pharmacies and CCG’s.

Fundamentally established as a pharmaceutical company, due to the success achieved with the licensed Trimovate cream, Ennogen wish to promote their medical device range with a particular focus in dermatological products. The most recent introduction is the Derma Protective Plus which Ennogen have introduced to offer a cost saving to the NHS.

Privacy Policy